アンジェスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/29 | 2,022 | 2,127 | 2,000 | 2,114 | +131 | +6.6% | 25,036,600 |
2020/05/28 | 2,010 | 2,070 | 1,881 | 1,983 | -87 | -4.2% | 37,179,500 |
2020/05/27 | 2,080 | 2,148 | 1,991 | 2,070 | -66 | -3.1% | 28,838,800 |
2020/05/26 | 2,113 | 2,309 | 1,860 | 2,136 | +203 | +10.5% | 71,547,400 |
2020/05/25 | 1,860 | 1,961 | 1,820 | 1,933 | +153 | +8.6% | 38,374,500 |
2020/05/22 | 1,837 | 1,894 | 1,768 | 1,780 | +22 | +1.3% | 35,971,100 |
2020/05/21 | 1,542 | 1,780 | 1,521 | 1,758 | +193 | +12.3% | 37,776,100 |
2020/05/20 | 1,552 | 1,593 | 1,468 | 1,565 | -39 | -2.4% | 18,031,600 |
2020/05/19 | 1,710 | 1,720 | 1,565 | 1,604 | -25 | -1.5% | 30,348,100 |
2020/05/18 | 1,500 | 1,637 | 1,477 | 1,629 | +200 | +14% | 28,174,800 |
2020/05/15 | 1,400 | 1,442 | 1,362 | 1,429 | +83 | +6.2% | 20,271,300 |
2020/05/14 | 1,370 | 1,408 | 1,323 | 1,346 | -6 | -0.4% | 15,910,100 |
2020/05/13 | 1,258 | 1,429 | 1,253 | 1,352 | +4 | +0.3% | 34,577,800 |
2020/05/12 | 1,469 | 1,520 | 1,320 | 1,348 | -151 | -10.1% | 32,024,200 |
2020/05/11 | 1,600 | 1,649 | 1,200 | 1,499 | -24 | -1.6% | 80,160,300 |
2020/05/08 | 2,223 | 2,455 | 1,523 | 1,523 | -500 | -24.7% | 91,134,600 |
2020/05/07 | 1,783 | 2,023 | 1,716 | 2,023 | +400 | +24.6% | 52,389,200 |
2020/05/01 | 1,599 | 1,680 | 1,486 | 1,623 | +134 | +9% | 62,463,800 |
2020/04/30 | 1,311 | 1,494 | 1,304 | 1,489 | +280 | +23.2% | 72,671,300 |
2020/04/28 | 1,118 | 1,220 | 1,115 | 1,209 | +42 | +3.6% | 37,004,400 |
2020/04/27 | 1,130 | 1,203 | 1,121 | 1,167 | +64 | +5.8% | 38,307,300 |
2020/04/24 | 1,033 | 1,235 | 1,021 | 1,103 | +71 | +6.9% | 76,209,000 |
2020/04/23 | 999 | 1,034 | 970 | 1,032 | +39 | +3.9% | 20,657,000 |
2020/04/22 | 973 | 1,013 | 963 | 993 | +11 | +1.1% | 20,935,300 |
2020/04/21 | 921 | 1,021 | 916 | 982 | +67 | +7.3% | 43,419,200 |
2020/04/20 | 920 | 930 | 904 | 915 | +20 | +2.2% | 11,375,900 |
2020/04/17 | 909 | 924 | 883 | 895 | +5 | +0.6% | 11,135,100 |
2020/04/16 | 876 | 899 | 865 | 890 | -9 | -1% | 12,668,400 |
2020/04/15 | 894 | 929 | 855 | 899 | -9 | -1% | 31,460,400 |
2020/04/14 | 850 | 908 | 838 | 908 | +150 | +19.8% | 37,292,100 |
2020/04/13 | 715 | 761 | 711 | 758 | +29 | +4% | 10,275,200 |
2020/04/10 | 697 | 729 | 694 | 729 | +20 | +2.8% | 6,909,000 |
2020/04/09 | 685 | 709 | 671 | 709 | +12 | +1.7% | 5,339,400 |
2020/04/08 | 710 | 715 | 684 | 697 | -10 | -1.4% | 6,489,100 |
2020/04/07 | 655 | 709 | 645 | 707 | +52 | +7.9% | 6,333,500 |
2020/04/06 | 675 | 683 | 636 | 655 | -35 | -5.1% | 5,963,500 |
2020/04/03 | 731 | 731 | 668 | 690 | -26 | -3.6% | 8,191,100 |
2020/04/02 | 729 | 738 | 707 | 716 | +13 | +1.8% | 8,171,600 |
2020/04/01 | 716 | 734 | 701 | 703 | +12 | +1.7% | 11,399,500 |
2020/03/31 | 705 | 722 | 687 | 691 | -9 | -1.3% | 6,885,800 |
2020/03/30 | 681 | 725 | 681 | 700 | -15 | -2.1% | 7,037,400 |
2020/03/27 | 742 | 750 | 697 | 715 | -3 | -0.4% | 11,658,900 |
2020/03/26 | 710 | 777 | 676 | 718 | +2 | +0.3% | 21,158,400 |
2020/03/25 | 728 | 750 | 670 | 716 | +36 | +5.3% | 23,439,800 |
2020/03/24 | 670 | 680 | 662 | 680 | +100 | +17.2% | 16,938,000 |
2020/03/23 | 600 | 608 | 573 | 580 | +14 | +2.5% | 5,589,200 |
2020/03/19 | 600 | 607 | 537 | 566 | -52 | -8.4% | 7,074,100 |
2020/03/18 | 661 | 689 | 574 | 618 | -106 | -14.6% | 15,455,200 |
2020/03/17 | 718 | 750 | 686 | 724 | +48 | +7.1% | 20,500,300 |
2020/03/16 | 639 | 689 | 613 | 676 | +87 | +14.8% | 18,710,200 |
1101~
1150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「アンジェス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アンジェス | 5,500円 | +294.7% | - | 0.00% | - | 0.59倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
ステラファーマ | 49,400円 | +245.7% | - | 0.00% | - | 5.46倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
メディシノバ | 31,200円 | - | - | - | - | - |
|
- |
NANO | 16,700円 | -20.0% | - | 0.00% | - | 3.88倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
シンバイオ | 25,500円 | -53.1% | - | 0.00% | - | 1.90倍 |
|
他社から新薬候補導入し開発、製品化。抗ウイルス薬「ブリンシドフォビル(BCV)」開発注力 |
市場注目の銘柄
チャート関連のコラム